                               SEQUENCE LISTING

<110> ONCOGENUITY, INC.
      ROSS, ARTHUR J
      ROSENWALD, LINDSAY
 
<120> METHODS AND COMPOSITIONS FOR TREATING SARS-COV-2 INFECTION USING 
      PEPTIDE NUCLEIC ACID-BASED AGENTS

<130> OG1100-1WO

<140>
<141>

<150> 63/026,601
<151> 2020-05-18

<160> 10    

<170> PatentIn version 3.5

<210> 1
<211> 17
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
aagttggttg gtttgtt                                                      17


<210> 2
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
gttggtttgt tacctg                                                       16


<210> 3
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
accaaccaac tttcga                                                       16


<210> 4
<211> 14
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
ttggttggtt tgtt                                                         14


<210> 5
<211> 17
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
ccaactttcg atctctt                                                      17


<210> 6
<211> 17
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 6
aacaaaccaa ccaactt                                                      17


<210> 7
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 7
caggtaacaa accaac                                                       16


<210> 8
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 8
tcgaaagttg gttggt                                                       16


<210> 9
<211> 14
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 9
aacaaaccaa ccaa                                                         14


<210> 10
<211> 17
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 10
aagagatcga aagttgg                                                      17


